Pura Vida Investments’s CorMedix CRMD Stock Holding History

Pura Vida Investments’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-13,350	Closed	-$127K	–	68
2014 Q4	$127K	Buy	+13,350	New	+$106K	0.05%	71

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return

Pura Vida Investments's CRMD Position: Q1 2015 in Review

Pura Vida Investments sold out of CorMedix (CRMD) in Q1 2015, closing a stake of 13,350 shares — an estimated $127K sold.

Pura Vida Investments first reported a position in CRMD in Q4 2014 and held it in 1 quarter. The position peaked at $127K in Q4 2014. 31 funds tracked by Wall St. Rank hold CRMD as of Q1 2015.

Pura Vida Investments reported no remaining CorMedix position as of Q1 2015 after selling out during the quarter.
Pura Vida Investments sold 13,350 CorMedix shares in Q1 2015, an estimated $127K.
Pura Vida Investments first reported a position in CorMedix in Q4 2014 and held it in 1 quarter.
Pura Vida Investments's CorMedix position peaked at $127K in Q4 2014.
31 funds tracked by Wall St. Rank held CorMedix as of Q1 2015.

Based on Pura Vida Investments's 13F filing for Q1 2015, filed 14 May 2015.